<<They have a unique formulation of phentolamine called Vasomax. >>
That may be true but without patent protection that means very little. As I look at ZONA (I still have no position) it appears to be a very high risk investment vehicle for eaither longs or shorts, to say the least. However, at its current price without a proprietary product, without FDA approval for that product, without even a NDA filed for that product, and with a major pharmaceutical industry player with a similar (in concept) product well ahead in the testing, review, approval, manufacturing, distribution, and sales force areas I would have to say the riskier position by far is that of the longs.
<<Many companies announce stock buybacks. It happens all the time, often
with excellent results. >>
Usually companies that buy back their shares have products, revenues and profits. And usually they haven't just issued new shares to raise the capital they will use in the share buy-back. I am not saying that ZONA is a scam. I just think they have made some very odd management decisions. |
